210 related articles for article (PubMed ID: 10824029)
1. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
Hannan PC; Woodnutt G
J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
[TBL] [Abstract][Full Text] [Related]
3. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Cohen MA; Huband MD
J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
[No Abstract] [Full Text] [Related]
4. Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.
Waites KB; Crabb DM; Duffy LB
Int J Antimicrob Agents; 2003 Jun; 21(6):574-7. PubMed ID: 12791472
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.
Rittenhouse S; McCloskey L; Broskey J; Niconovich N; Jakielaszek C; Poupard J; Coleman K
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():23-7. PubMed ID: 10824028
[TBL] [Abstract][Full Text] [Related]
8. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
Kerawala M; Ambler JE; Lee PY; Drabu YJ
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.
García MT; Pelaz C; Giménez MJ; Aguilar L
Antimicrob Agents Chemother; 2000 Aug; 44(8):2176-8. PubMed ID: 10898695
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.
Ieven M; Goossens W; De Wit S; Goossens H
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():51-3. PubMed ID: 10824033
[TBL] [Abstract][Full Text] [Related]
13.
Xue G; Crabb DM; Xiao L; Liu Y; Waites KB
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104279
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.
García-Garrote F; Cercenado E; Martín-Pedroviejo J; Cuevas O; Bouza E
J Antimicrob Chemother; 2001 May; 47(5):681-4. PubMed ID: 11328784
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA.
McCloskey L; Moore T; Niconovich N; Donald B; Broskey J; Jakielaszek C; Rittenhouse S; Coleman K
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():13-21. PubMed ID: 10824027
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of gemifloxacin.
King A; May J; French G; Phillips I
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():1-12. PubMed ID: 10824026
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.
Higgins PG; Coleman K; Amyes SG
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():71-7. PubMed ID: 10824036
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
Lemmen S; Al-Lahham A; Lütticken R; Reinert RR
Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
Goldstein EJ; Citron DM; Warren Y; Tyrrell K; Merriam CV
Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]